Treatment of Recurrent Esophageal Cancer

All patients with recurrent esophageal cancer should consider entering a clinical trial as outlined in the Treatment Option Overview section of this summary.

Treatment of recurrent esophageal cancer may include the following:

• Use of certain treatments as palliative therapy to relieve symptoms and improve quality of life.
• Immunotherapy (nivolumab) and chemoimmunotherapy for patients with recurrent esophageal squamous cell carcinoma.
• Clinical trials.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.